AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18922712
Drug: Few injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Few injections of >0.5 ml 1% polidocanol foam
Trial: 17278196
Drug: Tegaserod (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tegaserod (6 mg b.i.d.)
Trial: 15361727
Drug: Clarithromycin 30
RxNorm normalized name: lansoprazole/amoxicillin trihydrate/clarithromycin 30 mg-500 mg-500 mg ORAL COMBINATION PACKAGE (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 30 mg/kg/day b.i.d. for 5 days
Trial: 15361727
Drug: Clarithromycin 15
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin 15 mg/kg/day b.i.d. for 5 days
Trial: 15361727
Drug: Amoxicillin/clavulanate 43.8/6.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate 43.8/6.2 mg/kg/day b.i.d. for 5 days
Trial: 15361727
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V 30 mg/kg/day 3 times a day for 10 days
Trial: 11603222
Drug: 100 mg/day
RxNorm normalized name: infigratinib phosphate 100 mg/day (100 mg x 1) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/day of progesterone
Trial: 11603222
Drug: 300 mg/day
RxNorm normalized name: alpelisib 300 mg/day (150 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/day of progesterone
Trial: 11603222
Drug: 400 mg/day
RxNorm normalized name: ribociclib succinate 400 mg/day (200 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg/day of progesterone
Trial: 178687
Drug: Chronic E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic E administration (ethinyl estradiol 0.5 mg/day for 7 to 70 days)
Trial: 178687
Drug: iv administration
RxNorm normalized name: IV Administration Set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iv administration of E (bolus injection of 25 mg conjugated estrogens, USP)
Trial: 178687
Drug: iv administration
RxNorm normalized name: IV Administration Set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iv administration of normal saline
Trial: 27771320
Drug: Sterile water
RxNorm normalized name: sterile water
DrugBank: Water (DB09145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sterile water injections (SWI)
Trial: 18714500
Drug: Systane treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systane treatment
Trial: 30712496
Drug: Continuous subcutaneous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous subcutaneous infusion lignocaine
Trial: 26656722
Drug: Tele-thrombolysis (IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tele-thrombolysis (IV rt-PA administration in ER)
Trial: 27062408
Drug: K-877 0.025
FDA approved: no
EMA approved: no
PMDA approved: no
Description: K-877 0.025 mg BID
Trial: 27062408
Drug: K-877 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: K-877 0.05 mg BID
Trial: 27062408
Drug: K-877 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: K-877 0.1 mg BID
Trial: 27062408
Drug: K-877 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: K-877 0.2 mg BID
Trial: 16893712
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg warfarin initiation nomogram
Trial: 11160543
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A supplementation (two 7000‐microg retinol equivalent doses)
Trial: 8155452
Drug: Droperidol 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 1.25 mg and PCA containing morphine
Trial: 8155452
Drug: Droperidol 0.05
RxNorm normalized name: fentanyl citrate/droperidol 0.05-2.5MG INJECTION VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 0.05 mg mg‐1 of morphine in PCA
Trial: 8155452
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (placebo and PCA containing morphine)
Trial: 29684092
Drug: Short cycle
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short cycle therapy (SCT; 5 days on, 2 days off ART)
Trial: 29684092
Drug: Short cycle
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short cycle therapy (SCT)
Trial: 26460894
Drug: Competence and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Competence and Adherence Scale for Cognitive Behavioral Therapy (CAS‐CBT)
Trial: 25578377
Drug: Anthracycline-based chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthracycline-based chemotherapy (6 cycles)
Trial: 24434090
Drug: Once-daily dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily dosing
Trial: 24434090
Drug: Fast titration
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast titration
Trial: 24434090
Drug: Stimulant-naive patients
RxNorm normalized name: Staphylococcus simulans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulant-naive patients
Trial: 24434090
Drug: Twice-daily dosing
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily dosing
Trial: 20625120
Drug: Control (Arm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Arm A): four cycles of mitomycin (8 mg/m(2) on day 1)/vindesine (3 mg/m(2) on days 1, 8)/cisplatin (80 mg/m(2) on day 1) plus TRT 60 Gy
Trial: 20625120
Drug: Experimental (Arm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental (Arm B): weekly irinotecan (20 mg/m(2))/carboplatin (AUC 2) for 6 weeks plus TRT 60 Gy, followed by two courses of irinotecan (50 mg/m(2) on days 1, 8)/carboplatin (AUC 5 on day 1)
Trial: 20625120
Drug: Experimental (Arm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental (Arm C): weekly paclitaxel (40 mg/m(2))/carboplatin (AUC 2) for 6 weeks plus TRT 60 Gy, followed by two courses of paclitaxel (200 mg/m(2) on day 1)/carboplatin (AUC 5 on day 1)
Trial: 17330626
Drug: Metronidazole topical
RxNorm normalized name: MetroNIDAZOLE Topical
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole topical gel 0.75%
Trial: 15025849
Drug: PDRN ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PDRN ointment
Trial: 15025849
Drug: Control (non-adherent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (non-adherent gauzes and bulky gauzes with cloramine solution)
Trial: 11448900
Drug: Melanoma vaccine
RxNorm normalized name: melanoma vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melanoma vaccine (40 microg, bound to alum as an adjuvant)
Trial: 11448900
Drug: Placebo vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo vaccine (human albumin, bound to alum as an adjuvant)
Trial: 11448900
Drug: Melanoma vaccine
RxNorm normalized name: melanoma vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melanoma vaccine
Trial: 8275733
Drug: 167-ml chamber
RxNorm normalized name: POCKET CHAMBER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 167-ml chamber device (Device A)
Trial: 8275733
Drug: 700-ml chamber
RxNorm normalized name: POCKET CHAMBER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 700-ml chamber device (Device B)
Trial: 3050853
Drug: 25 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 micrograms dose of H. influenzae type b PRP vaccine
Trial: 3050853
Drug: 12.5 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 micrograms dose of H. influenzae type b PRP vaccine (used in 1974)
Trial: 17894054
Drug: Higher dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dosage of pizotyline
Trial: 17894054
Drug: Lower dosage
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower dosage of pizotyline
Trial: 27225761
Drug: Norepinephrine transporter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norepinephrine transporter blocker atomoxetine
Trial: 20180694
Drug: Sootshekhar Rasa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sootshekhar Rasa (250 mg) plus Sitopaladi Churna (400 mg) daily for 90 days
Trial: 20180694
Drug: Iron and
RxNorm normalized name: beef,iron and wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron and folic acid tablet for 90 days
Trial: 16996826
Drug: Prasugrel 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 60 mg loading dose followed by 10 mg daily
Trial: 16996826
Drug: Clopidogrel 300
RxNorm normalized name: clopidogrel 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 300 mg loading dose followed by 75 mg daily
Trial: 30281924
Drug: Fentanyl (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (300 μg oral dose)
Trial: 23163910
Drug: linagliptin 5
RxNorm normalized name: linagliptin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: linagliptin 5 mg and 10 mg
Trial: 16452736
Drug: Oral alendronate
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral alendronate at a dosage of 10 mg/day for six months
Trial: 15212653
Drug: GH replacement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH replacement therapy (0.017 mg/kg/week for 1 month, then 0.033 mg/kg/week)
Trial: 15212653
Drug: GH replacement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH replacement therapy (open study after 6 months)
Trial: 9215240
Drug: Injections of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injections of peanut extract (0.5 ml of 1:100 wt/vol peanut extract)
Trial: 9215240
Drug: Injections of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injections of peanut extract
Trial: 8305355
Drug: Prochlorperazine 10
RxNorm normalized name: prochlorperazine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prochlorperazine 10 mg t.d.s.
Trial: 11641293
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein supplement to increase protein intake to 25% energy
Trial: 11641293
Drug: Psyllium supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psyllium supplement to provide an additional 12 g soluble fiber/d
Trial: 11641293
Drug: Both protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both protein and fiber supplements
Trial: 2686456
Drug: Triphasic oral
RxNorm normalized name: CeeNU, triphasic oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triphasic oral contraceptives (ethinyl estradiol and levonorgestrel)
Trial: 2686456
Drug: Triphasic oral
RxNorm normalized name: CeeNU, triphasic oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triphasic oral contraceptives (ethinyl estradiol and norethindrone)
Trial: 2686456
Drug: Triphasic oral
RxNorm normalized name: CeeNU, triphasic oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triphasic oral contraceptives (all formulations)
Trial: 2686456
Drug: All triphasic
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All triphasic oral contraceptives
Trial: 30051179
Drug: Darbepoetin alfa
RxNorm normalized name: Darbepoetin Alfa
DrugBank: Darbepoetin alfa (DB00012)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Darbepoetin alfa treatment
Trial: 28676236
Drug: Treatment (nifedipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment (nifedipine controlled-release tablet)
Trial: 21224234
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of l‐carnitine‐l‐tartrate and 80 g of CHO (Carnitine)
Trial: 21224234
Drug: 80 g
RxNorm normalized name: PEG-80 GLYCERYL COCOATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 g of CHO (Control)
Trial: 15333727
Drug: 5 d/wk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 d/wk iron supplementation (Ferrous sulfate 300 mg)
Trial: 15333727
Drug: 1 d/wk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 d/wk iron supplementation (Ferrous sulfate 300 mg)
Trial: 7866806
Drug: sulglycotide 200
RxNorm normalized name: sulglicotide
DrugBank: Sulglicotide (DB13299)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sulglycotide 200 mg twice daily
Trial: 30447565
Drug: Sertraline -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline - Clinical Management (CM)
Trial: 30447565
Drug: Pill Placebo
RxNorm normalized name: placebo Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pill Placebo - Clinical Management (CM)
Trial: 30447565
Drug: All conditions
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All conditions (IPT, Sertraline-CM, Pill Placebo-CM)
Trial: 29478425
Drug: Day hospital
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Day hospital mentalization-based treatment (MBT-DH)
Trial: 29478425
Drug: Specialist treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specialist treatment as usual (S-TAU)
Trial: 24612221
Drug: Vildagliptin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin (50 mg BID)
Trial: 17903157
Drug: Endovenous laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovenous laser (EVL) treatment with a 980‐nm diode, plus clinical treatment
Trial: 17903157
Drug: Clinical treatment
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical treatment (elastic or inelastic compression therapy)
Trial: 11692348
Drug: Tramadol drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol drops 3 mg/kg plus oral midazolam 0.5 mg/kg
Trial: 11692348
Drug: Tramadol drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol drops 3 mg/kg
Trial: 7564670
Drug: Terlipressin combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terlipressin combined with glyceryl trinitrate (TER-GTN), intravenous injection (1 to 2 mg)
Trial: 7564670
Drug: Double-placebo injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-placebo injection
Trial: 31651877
Drug: High-dimensional test
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dimensional test for treatment effects
Trial: 31651877
Drug: Conventional test
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional test for treatment effects
Trial: 19388972
Drug: Nateglinide (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nateglinide (120 mg three times daily)
Trial: 3525684
Drug: Adjuvant systemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant systemic antibiotic therapy
Trial: 23939512
Drug: Yohimbine HCL
RxNorm normalized name: yohimbine HCl
DrugBank: Yohimbine (DB01392)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine HCL (single administration paired with the first session of imaginal exposure)
Trial: 22110589
Drug: 500 ml
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 ml orange juice daily for 4 weeks
Trial: 22110589
Drug: 500 ml
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 ml control drink plus hesperidin daily for 4 weeks
Trial: 22110589
Drug: 500 ml
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 ml control drink and placebo daily for 4 weeks
Trial: 16923110
Drug: Control (other
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (other therapies)
Trial: 10912889
Drug: 10% maltodextrin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% maltodextrin solution (Md)
Trial: 3919917
Drug: Intravenous hyperalimentation
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hyperalimentation (IVH) for 30 days
Trial: 27010683
Drug: 400 mg/day
RxNorm normalized name: ribociclib succinate 400 mg/day (200 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg/day of study medication
Trial: 27010683
Drug: 50 mg/day
RxNorm normalized name: infigratinib phosphate 50 mg/day (25 mg x 2) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/day of study medication (control)
Trial: 17030973
Drug: Culturally proficient
RxNorm normalized name: casein, emmental cultured
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Culturally proficient 14-week diet/physical activity intervention (three times weekly)
Trial: 15295782
Drug: Soft gelatin
RxNorm normalized name: Norvir Soft Gelatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft gelatin capsules with vitamin E TPGS (5 mg strength)
Trial: 15295782
Drug: Soft gelatin
RxNorm normalized name: Norvir Soft Gelatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft gelatin capsules without vitamin E TPGS (5 mg strength)
Trial: 11890241
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (active patient participation in treatment choice)
Trial: 11890241
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standardized treatment protocols)
Trial: 7530121
Drug: Alfuzosin (long-term
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfuzosin (long-term treatment)
Trial: 3057844
Drug: Propafenone 337.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 337.5 mg/day
Trial: 3057844
Drug: Propafenone 900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 900 mg/day
Trial: 3057844
Drug: Propafenone (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone (all doses)
Trial: 22402204
Drug: Interferon beta
RxNorm normalized name: Interferon beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon beta and low‐dose azathioprine
Trial: 22402204
Drug: Interferon beta,
RxNorm normalized name: Interferon beta, recombinant human
DrugBank: Interferon beta-1a (DB00060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon beta, azathioprine and low‐dose prednisone
Trial: 18164827
Drug: Drug skill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug skill refusal techniques
Trial: 16357552
Drug: Low-dose botulinum
RxNorm normalized name: Clostridium botulinum
DrugBank: Clostridium botulinum (DB14223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose botulinum toxin (100 units) with short-term electrical stimulation
Trial: 16357552
Drug: High-dose botulinum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose botulinum toxin (400 units)
Trial: 11305382
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate fatty cream, applied twice weekly for 6 months
Trial: 11305382
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate fatty cream
Trial: 8975837
Drug: Postoperative low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Postoperative low-dose aprotinin (2 million kallikrein inactivator units)
Trial: 1535579
Drug: Roxithromycin 150
RxNorm normalized name: roxithromycin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxithromycin 150 mg
Trial: 1535579
Drug: Roxithromycin 300
RxNorm normalized name: roxithromycin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxithromycin 300 mg
Trial: 6142218
Drug: Amantadine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amantadine (100 mg daily)
Trial: 30190053
Drug: Unified Protocol
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unified Protocol (UP) treatment, 12 weekly sessions
Trial: 21982055
Drug: 755 nm
RxNorm normalized name: NM-004
DrugBank: NM-004 (DB18066)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 755 nm laser therapy
Trial: 21982055
Drug: Tacrolimus cream
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus cream
Trial: 15909439
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (moist gauze)
Trial: 10537958
Drug: Continuous intrathecal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intrathecal baclofen infusion via a subcutaneously implanted programmable pump (SynchroMed, Medtronic)
Trial: 1830108
Drug: Isradipine 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine 5.0 mg once daily
Trial: 24837444
Drug: Weight change
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight change among treatment groups
Trial: 22592504
Drug: St John's
RxNorm normalized name: St john's wort
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: St John's wort (SJW) 900-1500 mg
Trial: 22592504
Drug: Sertraline 50-100
RxNorm normalized name: sertraline 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline 50-100 mg
Trial: 19891698
Drug: Subdermal testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subdermal testosterone implants (TI)